Measured Wealth Private Client Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52K Hold
254
﹤0.01% 647
2025
Q4
$1.82K Hold
254
﹤0.01% 652
2025
Q3
$2.71K Buy
+254
New +$2.49K ﹤0.01% 630
2025
Q1
Sell
-35,586
Closed -$531K 188
2024
Q4
$531K Buy
35,586
+14,449
+68% +$235K 0.17% 77
2024
Q3
$404K Buy
21,137
+5,643
+36% +$117K 0.14% 98
2024
Q2
$321K Buy
+15,494
New +$308K 0.11% 143

Other funds holding OGN

Measured Wealth Private Client Group's OGN Position: Q1 2026 in Review

Measured Wealth Private Client Group held its Organon & Co (OGN) position steady in Q1 2026 at 254 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Measured Wealth Private Client Group first reported a position in OGN in Q2 2024 and has held it in 6 quarters since. The position peaked at $531K in Q4 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Measured Wealth Private Client Group held 254 shares of Organon & Co worth $1.52K as of Q1 2026.
  • Measured Wealth Private Client Group left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #647 holding.
  • Measured Wealth Private Client Group first reported a position in Organon & Co in Q2 2024 and has held it in 6 quarters since.
  • Measured Wealth Private Client Group's Organon & Co position peaked at $531K in Q4 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.